Wanninger, Josef <br/><br/>
Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-kappaB, and STAT3 signaling pathways.  [electronic resource] 

 -  American journal of physiology. Gastrointestinal and liver physiology  Sep 2009 
 - G611-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-1547 
<br/><br/><label>Standard No.: </label>10.1152/ajpgi.90644.2008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adiponectin--metabolism<br/>Cell Culture Techniques<br/>Cell Line, Tumor<br/>Hepatocytes--drug effects<br/>Humans<br/>Interleukin-8--genetics<br/>Mitogen-Activated Protein Kinase 1--antagonists & inhibitors<br/>Mitogen-Activated Protein Kinase 3--antagonists & inhibitors<br/>NF-kappa B--antagonists & inhibitors<br/>Phosphorylation<br/>Protein Kinase Inhibitors--pharmacology<br/>RNA Interference<br/>RNA, Messenger--metabolism<br/>Receptors, Adiponectin--genetics<br/>Recombinant Proteins--metabolism<br/>STAT3 Transcription Factor--antagonists & inhibitors<br/>Signal Transduction<br/>Time Factors<br/>Up-Regulation<br/>p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors